Natalia Borruel

14.2k total citations · 2 hit papers
73 papers, 3.8k citations indexed

About

Natalia Borruel is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Natalia Borruel has authored 73 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Genetics, 33 papers in Epidemiology and 21 papers in Surgery. Recurrent topics in Natalia Borruel's work include Inflammatory Bowel Disease (47 papers), Microscopic Colitis (25 papers) and Gut microbiota and health (20 papers). Natalia Borruel is often cited by papers focused on Inflammatory Bowel Disease (47 papers), Microscopic Colitis (25 papers) and Gut microbiota and health (20 papers). Natalia Borruel collaborates with scholars based in Spain, United States and France. Natalia Borruel's co-authors include Francesc Casellas, Francisco Guarner, Chaysavanh Manichanh, Maria Antolı́n, Encarna Varela, Antonio Torrejón, J. R. Malagelada, Séverine Vermeire, Kathleen Machiels and Marta Pozuelo and has published in prestigious journals such as Gastroenterology, Gut and International Journal of Molecular Sciences.

In The Last Decade

Natalia Borruel

68 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The gut microbiota in IBD

2012 892 citations Chaysavanh Manichanh, Natalia Borruel et al. profile →
A microbial signature for Crohn's disease

2017 595 citations Victoria Pascal, Marta Pozuelo et al. Gut profile →

Peers

Countries citing papers authored by Natalia Borruel

Since Specialization

Citations

This map shows the geographic impact of Natalia Borruel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Borruel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Borruel more than expected).

Fields of papers citing papers by Natalia Borruel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalia Borruel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Borruel. The network helps show where Natalia Borruel may publish in the future.

Co-authorship network of co-authors of Natalia Borruel

This figure shows the co-authorship network connecting the top 25 collaborators of Natalia Borruel. A scholar is included among the top collaborators of Natalia Borruel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia Borruel. Natalia Borruel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology 2025 ·Biomarker Research ·(unknown), (unknown), (unknown), (unknown), L Mayorga, Claudia Herrera‐deGuise, Natalia Borruel, Antonio Rodríguez‐Sinovas, (unknown), (unknown), (unknown), Chaysavanh Manichanh	4
2	P658 Comparative Efficacy and Safety of Upadacitinib Versus Tofacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: A Matching-Adjusted Indirect Comparison 2023 ·Journal of Crohn s and Colitis ·Walter Reinisch, (unknown), Kamal Patel, Natalia Borruel, Gil Melmed, Lani R. Wegrzyn, G Levy, Dapo Ilo, Yuri Sánchez González, Remo Panaccione	2
3	JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases 2023 ·Frontiers in Medicine ·Claudia Herrera‐deGuise, (unknown), (unknown), Natalia Borruel	49
4	Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach 2021 ·Computational and Structural Biotechnology Journal ·(unknown), L Mayorga, (unknown), Joaquím Roca, Natalia Borruel, Francesc Casellas, Encarna Varela, Marta Pozuelo, Kathleen Machiels, Francisco Guarner, Séverine Vermeire, Chaysavanh Manichanh	38
5	Impact of the COVID-19 pandemic on the activity of advanced-practice nurses on a reference unit for inflammatory bowel disease 2021 ·Gastroenterología y Hepatología ·(unknown), Natalia Borruel, Virginia Robles, Claudia Herrera‐deGuise, L Mayorga, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Esperanza Zuriguel‐Pérez, Francesc Casellas	8
6	Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016 2019 ·Eurosurveillance ·Xavier Martínez‐Gómez, Adrián Curran, Magda Campins, Laia Alemany, José Ángel Rodrigo‐Pendás, Natalia Borruel, Xavier Castellsagué, Cristina Díaz de Heredia, F.A. Moraga Llop, Marta del Pino, Aureli Torné	33
7	A microbial signature for Crohn's disease breakdown → 2017 ·Gut ·Victoria Pascal, Marta Pozuelo, Natalia Borruel, Francesc Casellas, David Campos, Alba Santiago, Xavier Martínez, Encarna Varela, Guillaume Sarrabayrouse, Kathleen Machiels, Séverine Vermeire, Harry Sokol, Francisco Guarner, Chaysavanh Manichanh	595
8	Patient preferences for inflammatory bowel disease treatment objectives 2016 ·Digestive and Liver Disease ·Francesc Casellas, Claudia Herrera‐deGuise, Virginia Robles, (unknown), Natalia Borruel	48
9	P628 Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE Study) 2014 ·Journal of Crohn s and Colitis ·Ignacio Marín‐Jiménez, Cristina Saro, Víctor Díaz, Manuel Barreiro‐de Acosta, María Gómez–García, Natalia Borruel, A. Gutiérrez	1
10	Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment 2012 ·Journal of Crohn s and Colitis ·Francesc Casellas, Virginia Robles, Natalia Borruel, Antonio Torrejón, (unknown), (unknown), Francisco Guarner	25
11	Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease 2012 ·European Journal of Gastroenterology & Hepatology ·Francesc Casellas, Manuel Barreiro‐de Acosta, Marta Iglesias, Virginia Robles, Pilar Nos, Mariam Aguas, Sabino Riestra, Ruth de Francisco, Michel Papo, Natalia Borruel	77
12	Aplicación de un modelo de asistencia continuada en la enfermedad inflamatoria intestinal: la Unidad de Atención Crohn-Colitis 2009 ·Gastroenterología y Hepatología ·Antonio Torrejón, (unknown), Natalia Borruel, (unknown), (unknown), (unknown), Francesc Casellas	18
13	Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission 2008 ·The American Journal of Gastroenterology ·Cristina Martínez, Maria Antolı́n, Javier Santos, Antonio Torrejón, Francesc Casellas, Natalia Borruel, Francisco Guarner, Juan‐R. Malagelada	160
14	Lactobacillus casei downregulates commensalsʼ inflammatory signals in Crohnʼs disease mucosa 2008 ·Inflammatory Bowel Diseases ·Marta Llopis, Maria Antolı́n, Mónica Carol, Natalia Borruel, Francesc Casellas, Cristina Martínez, Eloy Espín, Francisco Guarner, Juan R. Malagelada	125
15	Probióticos y prebióticos en la enfermedad inflamatoria intestinal 2007 ·Gastroenterología y Hepatología ·Natalia Borruel	3
16	Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa 2003 ·The American Journal of Gastroenterology ·Natalia Borruel, Francesc Casellas, M. Carmen Antolín, Marta Llopis, Mónica Carol, (unknown), Javier Naval, Francisco Guarner, Juan R. Malagelada	109
17	Increased mucosal tumour necrosis factor α production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria 2002 ·Gut ·Natalia Borruel, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	254
18	Role of microecology in chronic inflammatory bowel diseases 2002 ·European Journal of Clinical Nutrition ·Francisco Guarner, Francesc Casellas, Natalia Borruel, Maria Antolı́n, Sebastián Videla, J Vilaseca, J. R. Malagelada	49
19	Helicobacter pylori eradication prevents recurrence from peptic ulcer haemorrhage 2000 ·European Journal of Gastroenterology & Hepatology ·Mercedes Vergara, Francesc Casellas, Esteban Saperas, (unknown), (unknown), Natalia Borruel, J Armengol, J. R. Malagelada	33
20	The Impact of Delaying Gastric Emptying by Either Meal Substrate or Drug on The [13C]-Urea Breath Test 1999 ·The American Journal of Gastroenterology ·Francesc Casellas, (unknown), Natalia Borruel, Esteban Saperas, Mercedes Vergara, (unknown), J Armengol, (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact